Track the EDGC stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, EDGC has logged 20 public disclosures. Market capitalisation: €47.5bn. The latest transaction was disclosed on 18 May 2026 (Purchase). Among the most active insiders: 에이아이티스토리. All data is openly available.
20
Insider Decl.
n/a
Thresholds
€9m
6 ops.
Buy Volume
n/a
6 ops.
Sell Volume
10Σ signal
Buys €9mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,195 of 28,803 companies
76.3
score / 100
Value
91
Quality
62
FCF yld7.3%
Earn yld59%
EV/EBITDA2.5x
ROE·
Gross mgn39%
Net mgn·
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
EDGC is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.